We are live on ! Find out more
PCA

Personal Capital Advisors Portfolio holdings

AUM $20.6B
1-Year Est. Return 13.65%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
-13.65%
3 Year Est. Return
+17.55%
5 Year Est. Return
+33.04%
10 Year Est. Return
–
AUM
$19.2B
AUM Growth
+$2B
Cap. Flow
+$1.11B
Cap. Flow %
5.76%
Top 10 Hldgs %
42.66%
Holding
510
New
35
Increased
264
Reduced
165
Closed
24

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$96.5M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$92.6M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$55.3M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$54.8M
5
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$54.6M

Top Sells

Rank Stock Value
1
NUE icon
Nucor
NUE
+$33.7M
2
VVV icon
Valvoline
VVV
+$31.1M
3
TXG icon
10x Genomics
TXG
+$24.8M
4
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$20M
5
PDBC icon
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
+$15M

Sector Composition

Rank Sector Weight
1 Technology 6.37%
2 Communication Services 4.28%
3 Consumer Discretionary 4.09%
4 Materials 3.95%
5 Financials 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MUB icon
301
iShares National Muni Bond ETF
MUB
$45.2B
$524K ﹤0.01%
4,469
-1,334
-23% -$156K
TFC icon
302
Truist Financial
TFC
$63.5B
$518K ﹤0.01%
9,342
-26
-0.3% -$1.53K
DFAT icon
303
Dimensional US Targeted Value ETF
DFAT
$14.7B
$516K ﹤0.01%
+11,513
New +$517K
XBI icon
304
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$516K ﹤0.01%
3,811
-306
-7% -$40.2K
XLU icon
305
State Street Utilities Select Sector SPDR ETF
XLU
$23B
$512K ﹤0.01%
16,180
+2,518
+18% +$82.4K
PRF icon
306
Invesco FTSE RAFI US 1000 ETF
PRF
$9.78B
$506K ﹤0.01%
15,795
-1,730
-10% -$55.1K
PAYC icon
307
Paycom
PAYC
$7.53B
$504K ﹤0.01%
1,388
+20
+1% +$7.09K
XLY icon
308
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$503K ﹤0.01%
5,638
-32
-0.6% -$2.79K
PM icon
309
Philip Morris
PM
$299B
$502K ﹤0.01%
5,063
-755
-13% -$72.4K
ZM icon
310
Zoom
ZM
$27.1B
$501K ﹤0.01%
1,295
+309
+31% +$103K
EMR icon
311
Emerson Electric
EMR
$83.3B
$499K ﹤0.01%
5,187
-556
-10% -$52.3K
GS icon
312
Goldman Sachs
GS
$302B
$498K ﹤0.01%
1,312
+108
+9% +$38.6K
NTAP icon
313
NetApp
NTAP
$34.1B
$487K ﹤0.01%
5,952
-20
-0.3% -$1.56K
MTUM icon
314
iShares MSCI USA Momentum Factor ETF
MTUM
$24.9B
$486K ﹤0.01%
2,804
+36
+1% +$6.1K
AZN icon
315
AstraZeneca
AZN
$266B
$478K ﹤0.01%
3,990
-704
-15% -$77.2K
FDX icon
316
FedEx
FDX
$73B
$478K ﹤0.01%
1,601
-54
-3% -$16K
MRSH
317
Marsh
MRSH
$91.4B
$472K ﹤0.01%
3,353
+878
+35% +$118K
ESML icon
318
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.83B
$470K ﹤0.01%
11,653
-2,104
-15% -$83.7K
ACWX icon
319
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$469K ﹤0.01%
8,149
– –
BDX icon
320
Becton Dickinson
BDX
$45.6B
$464K ﹤0.01%
1,955
-71
-4% -$17K
XLV icon
321
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$464K ﹤0.01%
3,686
+297
+9% +$36.4K
OXY icon
322
Occidental Petroleum
OXY
$55.6B
$463K ﹤0.01%
14,793
-1,409
-9% -$37.8K
MS icon
323
Morgan Stanley
MS
$330B
$459K ﹤0.01%
5,010
+254
+5% +$21.8K
IBB icon
324
iShares Biotechnology ETF
IBB
$9.52B
$458K ﹤0.01%
2,798
+100
+4% +$15.4K
ATVI
325
DELISTED
Activision Blizzard
ATVI
$456K ﹤0.01%
4,782
+1,979
+71% +$187K
11 12
13
14 15

Similar funds

PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Personal Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Personal Capital Advisors held 510 positions worth $19.2B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Personal Capital Advisors deployed $1.11B of net new capital in Q2 2021, opening 35 new positions and adding to 264 existing holdings. Its largest new stake was Hancock Whitney: 216,184 shares worth $9.61M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 5.8% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Nucor, an estimated $33.7M trimmed.

  • Personal Capital Advisors's largest Q2 2021 buy was Hancock Whitney: 216,184 shares worth $9.61M.
  • Personal Capital Advisors added most to Vanguard Short-Term Bond ETF in Q2 2021, an estimated $96.5M increase.
  • Personal Capital Advisors's biggest Q2 2021 reduction was Nucor, cutting an estimated $33.7M.
  • Personal Capital Advisors fully exited NiSource in Q2 2021, selling an estimated $5.21M.
  • Personal Capital Advisors's ten largest holdings make up 43% of its $19.2B portfolio in Q2 2021.
  • Personal Capital Advisors opened 35 new positions and closed 24 in Q2 2021.
  • Personal Capital Advisors's portfolio value rose 12% quarter-over-quarter to $19.2B.

Based on Personal Capital Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.